Edition:
United States

Odonate Therapeutics Inc (ODT.OQ)

ODT.OQ on NASDAQ Stock Exchange Global Select Market

24.98USD
22 Jun 2018
Change (% chg)

$0.16 (+0.64%)
Prev Close
$24.82
Open
$25.06
Day's High
$25.11
Day's Low
$23.19
Volume
77,049
Avg. Vol
26,142
52-wk High
$31.75
52-wk Low
$15.15

Chart for

About

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients... (more)

Overall

Beta: --
Market Cap(Mil.): $671.66
Shares Outstanding(Mil.): 26.89
Dividend: --
Yield (%): --

Financials

  ODT.OQ Industry Sector
P/E (TTM): -- 29.56 34.14
EPS (TTM): -1.79 -- --
ROI: -- 13.56 13.10
ROE: -- 15.35 15.09

BRIEF-Odonate Therapeutics Q4 Loss Per Share $0.81

* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2017

Feb 14 2018

Earnings vs. Estimates